A program to accompany you in your development
To support your fast track, orphan drug or breakthrough therapy designation, Eurofins CDMO tackles Early and Late Stage Development with regulatory support, speed and technical expertise. The Fast Track program is designed to facilitate the development and expedite the review and approval for your drug program.
Our approach
Our Fast Track Program facilitates progress towards clinical and commercial milestones. Through a multidisciplinary approach, our dedicated team, consisting of project management expertise, technical experience, and regulatory proficiency, is invested in your success.
- Project Management: Our team organizes and executes client program scope, budget and timelines through fostering client relationships, effective communication and proactive resolution management
- Technical Expertise: With three decades of technical experience, our team is well equipped to handle complex drug programs
- Regulatory Proficiency: Using a proactive CMC approach, our team ensures flexibility and planning for commercialization
Project Management
- Resource loaded plans
- Designated Action items
- Upfront agreement
- Ensure engagement of decision makers
- Escalation process
Technical Expertise
- Impurities Controls
- CMC Gap Analysis
- Available capacity
Talk to our CDMO experts